Next 10 |
home / stock / rcm / rcm articles
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NASDAQ:RCM) acquisitio...
NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NASDAQ:RCM) acquisitio...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the p...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition ...
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell sharply during Monday's session. Jefferies analyst Jonathan Matuszewski downgraded Arhaus from Buy t...
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition ...
NEW YORK, July 06, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NASDAQ:RCM) acquisitio...
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NASDAQ:RCM) acquisitio...
MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven soluti...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...